Natco Pharma received USFDA tentative approval for generic Olaparib tablets, a version of AstraZeneca’s Lynparza. Natco will manufacture, Alembic will distribute in the US.
Natco Pharma received USFDA tentative approval for generic Olaparib tablets, a version of AstraZeneca’s Lynparza. Natco will manufacture, Alembic will distribute in the US.